TCM
ABMD

Texan Capital Management’s Abiomed Inc ABMD Stock Holding History

Texan Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.04M Sell
10,872
-513
-5% -$95.8K 1.32% 31
2017
Q3 		$1.92M Sell
11,385
-394
-3% -$59.6K 1.27% 31
2017
Q2 		$1.69M Buy
11,779
+100
+0.9% +$13.4K 1.13% 34
2017
Q1 		$1.46M Buy
11,679
+2,960
+34% +$343K 0.67% 57
2016
Q4 		$982K Buy
+8,719
New +$1.01M 0.46% 75

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Texan Capital Management's ABMD Position: Q4 2017 in Review

Texan Capital Management reduced its Abiomed Inc (ABMD) stake by 4.5% in Q4 2017, selling an estimated $95.8K and leaving 10,872 shares worth $2.04M. The position accounts for 1.32% of the portfolio, ranked #31.

Texan Capital Management first reported a position in ABMD in Q4 2016 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Texan Capital Management held 10,872 shares of Abiomed Inc worth $2.04M as of Q4 2017.
  • Texan Capital Management sold 513 Abiomed Inc shares in Q4 2017, an estimated $95.8K.
  • Abiomed Inc made up 1.32% of Texan Capital Management's portfolio in Q4 2017, its #31 holding.
  • Texan Capital Management first reported a position in Abiomed Inc in Q4 2016 and has held it in 5 quarters since.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.